USSTOCK.TODAY
Weekend. Closed
Log in Sign up

Veradermix Announces Positive Phase 3 Clinical Data for Hair Loss Treatment

The Motley Fool +1 ·

MANE
MANE Veradermics Inc
$138.78 +0.21%
View chart & analysis →
  1. 1Veradermix announced that Phase 3 clinical data for VDPHL01 was positive.
  2. 2The rate of patients reporting improved hair coverage with twice-daily dosing reached 85%.
  3. 3Veradermix holds $820 million in cash as of the second quarter.

So what's the key point?

Veradermix announced positive results from its hair loss treatment trials. Hair coverage improved for 85 percent of patients, and the company has $820 million in cash.

Source The Motley Fool +1 · View original ↗

Related 3-line summaries

Iamgold improves profitability through expanded Côté Gold mine operations The Motley Fool +1 · 3h agoVanguard Information Technology ETF Noted as Rebound Candidate Following Market Sell-off The Motley Fool +1 · 3h agoAllied Gold ramps up Ethiopia mine production and maintains growth The Motley Fool +1 · 3h ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news